Five Western Australian life science companies will share in $450,000 of funding through the State Government’s Medical Technology and Pharmaceutical (MTP) Manufacturing Voucher Program to commercialise their innovations.
WA’s MTP Manufacturing Voucher Program was set up to accelerate the development and manufacturing of medical technology and pharmaceutical products in the state, such as medical devices, diagnostics, biologics and pharmaceuticals.
It was delivered by the MTPConnect WA Life Sciences Innovation Hub, which is currently co-funded through the State Government’s New Industries Fund, industry growth centre MTPConnect and The University of Western Australia.
The successful recipients are:
- OncoRes Medical – enabling clinical feasibility of a diagnostic imaging device for cancer surgery;
- Proteomics International – For manufacturing a next generation in vitro device to predict diabetic kidney disease;
- SynGenis – establishing certified oligonucleotide manufacturing capabilities in WA;
- VeinTech – developing its ground breaking VeinWave product in WA; and
- VitalTrace – developing Perth into Australia’s flagship precision healthcare biosensor development and manufacturing hub.
As part of the application process, the successful recipients will match the funding received through the program.
WA’s State Development, Jobs and Trade Minister Roger Cook said the successful projects would establish capability currently unavailable in WA, and would enable the manufacturing of MTP products to help diversify the economy.
“The McGowan Government is committed to investing in the promising ideas that are generated in our State, as what we produce in Western Australia ends up benefiting the world,” the Minister said.
“We have an enormous opportunity to capitalise on home-grown medical technology to help diversify the economy and create more manufacturing jobs.
“The five successful recipients of this funding represent the type of cutting-edge research and technology that our State is capable of developing, and we want to support these companies to bring their products to market.”
